Growth Metrics

Inogen (INGN) Liabilities and Shareholders Equity (2013 - 2026)

Inogen (INGN) reported Liabilities and Shareholders Equity of $285.9 million for Q1 2026, down 7.29% year-over-year from $308.4 million in Q1 2025, and down 4.25% on a QoQ basis from $298.6 million in Q4 2025.

Inogen (INGN) has 14 years of Liabilities and Shareholders Equity data on file, last reported at $285.9 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 7.29% year-over-year to $285.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 1.32% YoY) and the FY2025 annual result came in at $298.6 million, up 0.82% from the prior year.
  • Liabilities and Shareholders Equity declined to $285.9 million in Q1 2026 per INGN's latest filing, from $298.6 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $474.6 million in Q1 2022 and bottomed at $285.9 million in Q1 2026.
  • The 5-year median for Liabilities and Shareholders Equity is $315.6 million (2024), against an average of $352.2 million.
  • The widest annual swing landed in 2023, when Liabilities and Shareholders Equity fell 26.81%; it then increased 1.01% in 2025.
  • Tracing INGN's Liabilities and Shareholders Equity over 5 years: stood at $405.0 million in 2022, then declined by 19.47% to $326.2 million in 2023, then retreated by 9.2% to $296.2 million in 2024, then rose by 0.82% to $298.6 million in 2025, then fell by 4.25% to $285.9 million in 2026.
  • Per Business Quant, the three latest INGN Liabilities and Shareholders Equity figures stand at $285.9 million (Q1 2026), $298.6 million (Q4 2025), and $307.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 46.29 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 37.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 10.74 Bn
10 Inogen 165.85 Mn 71.44 Mn 37.86 Mn 285.93 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 285.93 Mn
Dec 31, 2025 298.63 Mn
Sep 30, 2025 307.01 Mn
Jun 30, 2025 312.04 Mn
Mar 31, 2025 308.41 Mn
Dec 31, 2024 296.19 Mn
Sep 30, 2024 306.17 Mn
Jun 30, 2024 308.92 Mn
Mar 31, 2024 315.60 Mn
Dec 31, 2023 326.19 Mn
Sep 30, 2023 343.70 Mn
Jun 30, 2023 374.35 Mn
Mar 31, 2023 385.67 Mn
Dec 31, 2022 405.04 Mn
Sep 30, 2022 469.58 Mn
Jun 30, 2022 470.07 Mn
Mar 31, 2022 474.62 Mn
Dec 31, 2021 489.51 Mn
Sep 30, 2021 512.86 Mn
Jun 30, 2021 498.17 Mn
Mar 31, 2021 476.48 Mn
Dec 31, 2020 461.85 Mn
Sep 30, 2020 460.33 Mn
Mar 31, 2020 459.12 Mn
Dec 31, 2019 447.34 Mn
Sep 30, 2019 444.73 Mn
Jun 30, 2019 403.77 Mn
Mar 31, 2019 388.20 Mn
Dec 31, 2018 375.90 Mn
Sep 30, 2018 357.11 Mn
Jun 30, 2018 332.64 Mn
Mar 31, 2018 299.88 Mn
Dec 31, 2017 275.07 Mn
Sep 30, 2017 269.84 Mn
Jun 30, 2017 251.23 Mn
Mar 31, 2017 227.63 Mn
Dec 31, 2016 214.05 Mn
Sep 30, 2016 211.31 Mn
Jun 30, 2016 197.52 Mn
Mar 31, 2016 180.78 Mn
Dec 31, 2015 161.31 Mn
Sep 30, 2015 157.47 Mn
Jun 30, 2015 157.20 Mn
Mar 31, 2015 148.46 Mn
Dec 31, 2014 140.09 Mn
Sep 30, 2014 137.15 Mn
Jun 30, 2014 145.47 Mn
Mar 31, 2014 135.51 Mn
Dec 31, 2013 82.40 Mn